Mesoblast (MESO) FCF Margin Growth (1y) (2015 - 2023)
Powered by 
Analysis
Mesoblast (MESO) FCF Margin Growth (1y) (2015 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 26,102.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 869.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 769.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 811.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 19,111.00 |
| 10 | Mesoblast | 2.24 Bn | 2.14 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 662,330.00 |
| Mar 31, 2023 | -323,716.00 |
| Dec 31, 2022 | 128,628.00 |
| Sep 30, 2022 | 44,419.00 |
| Jun 30, 2022 | 27,490.00 |
| Mar 31, 2022 | 50,615.00 |
| Dec 31, 2021 | 84,933.00 |
| Sep 30, 2021 | 266,476.00 |
| Mar 31, 2021 | -116,092.00 |
| Dec 31, 2020 | -89,676.00 |
| Sep 30, 2020 | -206,713.00 |
| Mar 31, 2020 | 157,954.00 |
| Dec 31, 2019 | -36,316.00 |
| Sep 30, 2019 | 7,669.00 |
| Mar 31, 2019 | 13,558.00 |
| Dec 31, 2018 | 631.00 |
| Sep 30, 2018 | 156,595.00 |
| Jun 30, 2018 | 295,293.00 |
| Mar 31, 2018 | 101,722.00 |
| Dec 31, 2017 | 453,213.00 |